Apoptosis and the pathogenesis of IDDM: A question of life and death

Diabetes

Volumn 47, Issue 10, 1998, Pages 1537-1543

  Mauricio, Dídac ^a   Mandrup Poulsen, Thomas ^b  

^a Endocrine Unit   (Spain)

^b STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYTOKINE; FAS ANTIGEN; NITRIC OXIDE;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; AUTOIMMUNITY; CELL DEATH; DIABETES MELLITUS; DIABETOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; REVIEW;

ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; LYMPHOCYTES; NITRIC OXIDE;

EID: 0031667779     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.10.1537     Document Type: Review

References (76)

1. Cohen JJ: Programmed cell death in the immune system. Adv Immunol 50:55-85, 1991
2. Steller H: Mechanisms and genes of cellular suicide. Science 267:1445-1449, 1995
3. Hale AJ, Smith CA, Sutherland LC, Stoneman VEA, Longthorne VL, Culhane AC, Williams GT: Apoptosis: molecular regulation of death. Eur J Biochem 236:1-26, 1996
4. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462, 1995
5. Cohen JJ: Apoptosis: physiologic cell death. J Clin Lab Med 124:761-765, 1994
6. Martin SJ: Apoptosis: suicide, execution or murder? Trends Cell Biol 3:141-144, 1993
7. Cohen JJ: Overview: mechanisms of apoptosis. Immunol Today 14:126-130, 1993
8. Vaux DL, Aguila HL, Weissman IL: Bcl-2 prevents death of factor-deprived cells but fails to prevent apoptosis in targets of cell mediated killing, Int Immunol 4:821-824, 1992
9. Castaño L, Eisenbarth GS: Type I diabetes: a chronic autoimmune disease of human, mouse, and rat. Annu Rev Immunol 8:647-679, 1990
10. Cohen JJ, Duke RC, Fadok VA, Sellins KS: Apoptosis and programmed cell death in immunity. Ann Rev Immunol 10:267-293, 1992
11. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA, Matis LA: The role of Fas in autoimmune diabetes. Cell 89:17-24, 1997
12. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S: The cDNA struture, expression and chromosomal assignment of the mouse Fas antigen. J Immunol 148:1274-1279, 1992
13. Nagata S, Golstein P: The Fas death factor. Science 267:1449-1456, 1995
14. Ramsdell F, Seaman MS, Miller RE, Picha KS, Kennedy MK, Lynch DH: Differential ability of Th1 and Th2 T cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 6:1545-1553, 1994
15. Ju ST, Cui H, Panka DJ, Ettinger R, Marshak-Rothstein A: Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T-cells. Proc Natl Acad Sci U S A 91:4185-4189, 1994
16. Rocha B, von Boehmer H: Peripheral selection of the T-cell repertoire. Science 251:1225-1228, 1991
17. Kabelitz D, Pohl T, Pechhold K: Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol Today 14:338-339, 1993
18. Klas C, Debatin KM, Jonker RR, Kramer PH: Activation interferes with APO-1 pathway in mature human T-cells. Int Immunol 5:625-630, 1993
19. Chu JL, Ramos P, Rosendrff A, Nikolic-Zugic J, Lacy E, Matsuzawa A, Elkon KB: Massive up-regulation of the Fas ligand in lpr and gld mice: implications for Fas regulation and the graft-versus-host disease-like wasting syndrome. J Exp Med 181:393-398, 1995
20. Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76:969-976, 1994
21. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317, 1992
22. Garchon HJ, Bédossa P, Eloy L, Bach JF: Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice. Nature 353:262-265, 1991
23. Leijon K, Hammarström B, Holmberg D: The non-obese diabetic (NOD) mouse displays enhanced immune responses and prolonged survival of lymphoid cells. Int Immunol 6:339-345, 1994
24. Garchon HJ, Luan JJ, Eloy L, Bédossa P, Bach JF: Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur J Immunol 24:380-384, 1994
25. Penha-Gonçalves C, Leijon K, Persson L, Holmberg D: Type 1 diabetes and the control of dexamethasone-induced apoptosis in mice maps to the same region on chromosome 6. Genomics 28:398-404, 1995
26. Colucci F, Cilio CM, Lejon K, Penha-Gonçalves C, Bergman ML, Holmberg D: Programmed cell death in the pathogenesis of murine IDDM: resistance to apoptosis induced in lymphocytes by cyclophosphamide. J Autoimmun 9:271-276, 1996
27. Lamhamedi-Cherradi SE, Luan JJ, Eloy L, Fluteau G, Bach JF, Garchon HJ: Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulation of Bcl-x. Diabetologia 41:178-184, 1998
28. Giordano C, De Maria R, Stassi G, Todaro M, Richiusa P, Giordano M, Testi R, Galluzzo A: Defective expression of the apoptosis-inducing CD95 (Fas/APO-1) molecule on T- and B-cells in IDDM. Diabetologia 38:1449-1454, 1995
29. Liu CC, Young LHY, Young JD: Lymphocyte-mediated cytolysis and disease. N Engl J Med 335:1651-1659, 1996
30. Mandrup-Poulsen T: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
31. Nerup J, Mandrup-Poulsen T, Helqvist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T: On the pathogenesis of IDDM. Diabetologia 37:S82-S89, 1994
32. Welsh N, Eizirik DL, Bendtzen K, Sandler S: Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129:3167-3173, 1991
33. Delaney CA, Green MHL, Lowe JE, Green IC: Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the "comet" assay. FEBS Lett 333:291-295, 1993
34. Fehsel K, Jalowy A, Qi S, Burkart V, Hartmann B, Kolb H: Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42:496-500, 1993
35. Heller B, Wang Z-Q, Wagner EF, Radons J, Burkle J, Fehsel K, Burkart V, Kolb H: Inactivation of the poly (ADP-ribose) polymerase gene affects oxygen radical and nitric oxide toxicity in islet cells. J Biol Chem 270:11176-11180, 1995
36. Xie K, Huang S, Zhongyun D, Fidler U: Cytokine-induced apoptosis in transformed murine fibroblasts involves synthesis of endogenous nitric oxide. Int J Oncol 3:104-3-1048, 1993
37. Scaglia L, Smith FE, Bonner-Weir S: Apoptosis contributes to the involution of β-cell mass in the post partum rat pancreas. Endocrinology 136:5461-5468, 1995
38. Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC: Vulnerability of islets in the immediate posttransplantation period: dynamic changes in structure and function. Diabetes 45:1161-1167, 1996
39. Sánchez-Margalet V, Lucas M, Solano F, Goberna K: Sensitivity of insulin-secreting RIN m5F cells to undergoing apoptosis by the protein kinase inhibitor staurosporine. Exp Cell Res 209:160-163, 1993
40. Loweth AC, Scarpello JHB, Williams GT, Morgan NG: Effects of modulators of G-protein function on apoptosis in RINm5F cells and rat islets (Abstract). Diabetologia 38 (Suppl. 1):A45, 1995
41. Ankarcrona M, Dypbukt JM, Brüne B, Nicotera P: Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213: 172-177, 1994
42. Morgan NG, Cable HC, Newcombe NR, Williams GT: Treatment of cultured pancreatic B-cells with streptozotocin induces cell death by apoptosis. Biosci Rep 14:243-250, 1994
43. Kaneto A, Schlosser M, Ziegler B, Schmidt S: Interleukin-1-beta induces apoptosis in insulin-producing cells (Abstract). Diabetologia 38 (Suppl. 1):A38, 1995
44. Dunger A, Augstein P, Schmidt S, Fischer U: Identification of interleukin 1-induced apoptosis in rat islets using in situ specific labelling of fragmented DNA. J Autoimmun 9:309-313, 1996
45. Dunger A, Schlosser M, Ziegler B, Schmidt S: Interleukin 1-beta induces apoptosis in insulin-producing cells (Abstract). Diabetologia 38 (Suppl. 1):A38, 1995
46. Rabinovitch A, Suarez-Pinzon WL, Shi Y, Morgan AR, Bleackley RC: DNA fragmentation is an early event in cytokine-induced islet beta-cell destruction. Diabetologia 37:733-738, 1994
47. 2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J Biol Chem 271:8307-8312, 1996
48. Jarvis WD, Kolesnick RN, Fornari FA, Traylor RS, Gewirtz DA, Grant S: Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc Natl Acad Sci U S A 91:73-77, 1994
49. Kwon G, Corbett JA, McDaniel ML: Interleukin 1-induced fos and jun do not regulate inducible nitric oxide synthase in rat islets of Langerhans and RINm5F cells. Endocrinology 137:825-830, 1996
50. Iwahashi H, Hanafusa T, Eguchi Y, Nakajima J, Itoh N, Tomita K, Namba M, Kuwajima M, Noguchi T, Tsujimoto Y, Matsuzawa Y: Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. Diabetologia 39:530-536, 1996
51. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL: Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138:2610-2614, 1997
52. Ankarcrona M, Dypbukt JM, Brüne B, Nicotera P: Interleukin-1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 212:172-177, 1994
53. Messmer UK, Ankarcrona M, Nicotera P, Brüne B: p53 Expression in nitric oxide-induced apoptosis. FEBS Lett 355:23-26, 1994
54. Kaneto H, Fujii J, Seo HG, Suzuki K, Matsuoka T, Nakamura M, Tatsumi H, Yamasaki Y, Kamada T, Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44:733-738, 1995
55. Loweth AC, Williams GT, Scarpello JHB, Morgan NG: Evidence for the involvement of cGMP and protein kinase G in nitric oxide-induced apoptosis in the pancreatic β-cell line, HIT-T15. FEBS Lett 400:285-288, 1997
56. Suarez-Pinzon WL, Strynadka K, Schulz R, Rabinovitch A: Mechanisms of cyotkine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology 134:1006-1010, 1994
57. Rabinovitch A, Suarez-Pinzon WL, Strynadka K, Schulz R, Lakey JR, Warnock GL, Rajotte RV: Human pancreatic islet β-cell destruction by cytokines is independent of nitric oxide production. J Clin Endocrinol Metab 79:1058-1062, 1994
58. Eizirik DL, Sandler S, Welsh N, Cetkovic-Cvrlje M, Nieman A, Geller DA, Pipeleers DG, Bendtzen K, Hellerstrom C: Cytokines supress human islet function irrespective of their effects on nitric oxide generation. J Clin Invest 93:1968-1974, 1994
59. Cetkovic-Cvrlje M, Sandier S, Eizirik DL: Nicotinamide and dexamethasone inhibit interleukin-1-induced nitric oxide production by RINm5F cells without decreasing messenger ribonucleic acid expression for nitric oxide synthase. Endocrinology 133:1739-1743, 1993
60. Andersen HU, Jørgensen KH, Egeberg J, Mandrup-Poulsen T, Nerup J: Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 43:770-777, 1994
61. Eizirik DL, Delaney CA, Green MHL, Cunningham JM, Thorpe JR, Pipeleers DG, Hellerstrom C, Green IC: Nitric oxide donors decrease the function and survival of human pancreatic islets. Mol Cell Endocrinol 118:71-83, 1996
62. Lukic ML, Stosic-Grujicic S, Ostojic N, Chan WL, Liew FY: Inhibition of nitric oxide generation affects the induction of diabetes by streptozotocin in mice. Biochem Biophys Res Commun 178:913-920, 1991
63. Corbett JA, Mikhael A, Shimizu J, Frederick K, Misko TP, McDaniel ML, Kaganawa O, Unanue ER: Nitric oxide production in islets from nonobese diabetic mice: aminoguanidine-sensitive and -resistant stages in the immunological diabetic process. Proc Natl Acad Sci USA 90:8992-8995, 1993
64. G-Nitro-L-Arginine methyl ester reduces the incidence of IDDM in BB/E rats. Diabetes 44:365-368, 1995
65. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K: Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39:1306-1312, 1996
66. Giordano C, Stassi G, De Maria R, Todaro M, Richiusa P, Papoff G, Ruberti G, Bagnasco M, Testi R, Galluzzo A: Potential involvement of Fas and its ligand in the pathogenesis of Hashimotos thyroiditis. Science 275:960-963, 1997
67. Stassi G, Todaro M, Richiusa P, Giordano M, Mattina A, Sbriglia MS, Lo Monte A, Buscemi G, Galluzzo A, Giordano C: Expression of apoptosis-inducing CD95 (Fas/Apo-1) on human β-cells sorted by flow-cytometry and cultured in vitro. Transplant Proc 27:3271-3275, 1995
68. Wyllie AH, Kerr JFR, Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306, 1980
69. Schwartzman RA, Cidlowski JA: Apoptosis: the biochemistry and molecular biology of programmed cell death. Endocr Rev 14:133-151, 1993
70. Kurrer MO, Pakala SV, Hanson HL, Katz JD: β-cell apoptosis in T-celi-mediated autoimmune diabetes. Pror Natl Acad Sci USA 94:213-218, 1997
71. O'Brien BA, Harmon BV, Cameron DP, Allan DJ: Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model. J Pathol 178:176-181, 1996
72. O'Brien BA, Harmon BV, Cameron DP, Allan DJ: Apoptosis is the mode of β-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse. Diabetes 46:750-757, 1997
73. 2+ channels exposed to serum from patients with type I diabetes. Science 261:86-90, 1993
74. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T-lymphocytes in T-cell receptor transgenic mice. Immunity 1:365-371, 1994
75. Kroemer G, Martínez AC: Pharmacological inhibition of programmed lymphocyte death. Immunol Today 15:235-242, 1994
76. Gladstone P, Nepom GT: The prevention of IDDM: injecting insulin into the cytokine network (Letter). Diabetes 44:859-862, 1995